Cell Methods: Molecular Events in the Progression of Human Tumor Cell Lines
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Methods".
Deadline for manuscript submissions: closed (25 September 2023) | Viewed by 8429
Special Issue Editor
2. Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, Avda, Universidad s/n, Ed. Torregaitán, Elche, 03202 Alicante, Spain
Interests: biological systems; neuroscience; cancer; new therapies; drug delivery systems
Special Issue Information
Dear Colleagues,
Multiple events lead to the beginning and development of cancer, and the understanding of the fundamentals of how cancer cells form and proliferate has become crucial to cancer treatment and prevention. It is important to know how tumors form, why they persist, and the reasons underlying their spread through the body since those steps will have an impact on the prognosis of cancer patients. The uncontrolled growth exhibited by cancer cells results in accumulated abnormalities in multiple cell regulatory systems and is reflected in several aspects of cell behavior that distinguish cancer cells from their normal counterparts. The development of new tools, together with genomic and computational technologies, has helped to increase our knowledge regarding these cellular changes that drive cancer. Now, we have the capacity to characterize and compare thousands of patient tumors to identify factors that influence cancer behavior. However, it has recently become clear that only a small fraction of tumor cells within a single tumor may have the capacity to divide and sustain tumor growth. Therefore, studying human cancer on a cell-by-cell basis is critical to understand the clinical consequences. In this issue, we address the approaches followed by tumor cells at the different stages of tumor initiation, progression, and metastasis and the clinical relevance.
Dr. Camino de Juan Romero
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- cell death
- new strategies
- proliferation
- cancer treatment
